AQST R&D Expenses
Aquestive Therapeutics Inc · R&D Expenses
AQST R&D Expenses
Latest reported$15.89Mperiod ending
AQST R&D Expenses ($15.45M → $15.89M)
Annual R&D Expenses
High-resolution chart · PNG
AQST r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 17,192,000 | |
| 20,280,000 | |
| 13,104,000 | |
| 17,481,000 | |
| 17,047,000 | |
| 19,886,000 | |
| 20,574,000 | |
| 23,112,000 | |
| 22,133,000 | |
| 15,450,000 |